BCA's Wall of Hope New and Improved!

Over the past few weeks, BCA member Tammie Harrison has been working with Downing Displays to improve the BCA Wall of Hope. Each photo was scanned and downloaded onto a new, sturdier format. The new Wall of Hope was unveiled this past Saturday at our annual Survivorship Celebration. Tim Bonn of B&B Studios took over two dozen additional individual photos which will be added to the display. For the next month, the Wall of Hope will be on display at UC Health-West Chester Medical Center 7700 University Drive in West Chester, Ohio.

If you are a breast cancer survivor and a member of the BCA who would like to be featured on the Wall of Hope, please visit:

www.bcacincy.org

Brighton Collectibles

The Brighton Collectible store at the Kenwood Towne Center will be selling the 2010 Power of Pink Bracelet through October 31. For each bracelet purchased, Brighton will donate $10.00 to the BCA.

Since 2003, Brighton has donated more than $3.1 million to breast cancer organizations from the sale of their Power of Pink jewelry.

Thank you Brighton for your continued support of the BCA!

Save the Date! Sing for a Cause

The choirs from three area high schools (Taylor, Sycamore and Lakota) will put on a benefit concert on Saturday, February 26, 2011 at 7pm at the Good Shepherd Lutheran Church in Kenwood.

All proceeds from ticket sales will go towards the BCA and a local Alzheimer's group. Tickets will cost $10 for adults and $5 for students.

Hot Topic

Hormone Replacement Therapy (HRT)

An update to the Women's Health Initiative (WHI) was published in the Journal of the American Medical Association (JAMA) this month, reporting that the use of combination hormone replacement therapy (estrogen plus progestin) increases breast cancer mortality. The update reported on 11 years of follow-up of the effects of combination hormone therapy on breast cancer incidence and mortality. The WHI randomized trial evaluating this combination therapy was stopped after a mean of 5.6 years because of the increased incidence of breast cancer seen in the combination group. Once this result was published, the use of combination therapy declined significantly followed by a reduction in the incidence of breast cancer.

With the longer follow-up reported, the investigators were able to look at a somewhat different question in addition to whether combination therapy increased the cumulative incidence of breast cancer: whether it increased death from breast cancer.

The updated data from this randomized, placebo-controlled trial of 12,788 postmenopausal women show that combination hormone replacement therapy not only increases the incidence of breast cancer, but also the incidence of more advanced cancers and the number of deaths from breast cancer. Combination therapy was also associated with an increase in overall death.

To read more about this study:

http://health.usnews.com/health-news/family-health/cancer/articles/2010/10/19/study-shows-hrt-even-riskier-than-thought.html